The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 ...
The HPV vaccine is very safe and highly effective at preventing cervical cancer, according to two large reviews that support ...
The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.
Make no mistake about it: We're living in a time where there seems to be not much good news in sight, and women's health care—specifically with regard to cancer rates increasing among young women—is ...
HPV vaccines aim to prevent the types of HPV infections that sometimes cause cancers and anogenital warts. The HPV vaccines do not work as well in people that have already been exposed to HPV, so most ...
WASHINGTON (AP) — A single HPV vaccination appears just as effective as two doses at preventing the viral infection that ...
V503-064 is a Phase 3, double-blind, placebo-controlled clinical study (NCT04635423) to evaluate the safety/tolerability and efficacy of GARDASIL 9 (V503) in preventing HPV-related anogenital ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results